Health-related quality of life (HRQoL) in newly diagnosed patients (pts) with chronic phase chronic myelogenous leukemia (CP CML) treated with bosutinib (BOS) or imatinib (IM).
J. H. Lipton
No relevant relationships to disclose
P. C. Trask
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
D. Cella
No relevant relationships to disclose
L. Duvillie
Employment or Leadership Position - Pfizer
C. Powell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
M. V. Ramanan
Other Remuneration - Pfizer
Z. Maslyak
No relevant relationships to disclose
D. Kim
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer